The global Merkel cell carcinoma therapeutics market is witnessing steady growth due to the increasing prevalence of Merkel cell carcinoma (MCC), rising awareness about rare skin cancers, and continuous advancements in immunotherapy treatments. According to recent market analysis, the global market size was valued at USD 3.24 billion in 2024 and is projected to grow from USD 3.36 billion in 2025 to USD 4.53 billion by 2033, registering a CAGR of 3.78% during the forecast period from 2025 to 2033.
